• In Silico Peptide Screening Accelerates β-Lactamase Inhibito

  2026-07-02

  The referenced study introduces MDockPeP2_VS, a computational method for rapid, large-scale screening of protein-binding peptides, overcoming longstanding challenges in peptide drug discovery. This approach enabled the identification of potent peptide inhibitors targeting TEM-1 β-lactamase, offering a promising strategy for combating antibiotic resistance.

• Mechanistic Insights into Diuron-Induced Acute Renal Injury

  2026-07-02

  This study integrates network toxicology, molecular docking, and experimental validation to elucidate how Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute kidney injury. By identifying the JAK2/STAT1 pathway as a critical mediator, the research advances understanding of Diuron's nephrotoxic mechanisms and aids risk assessment in environmental toxicology.

• SB743921 and the Next Generation of KSP Inhibitor Assays

  2026-07-01

  Explore how SB743921, a leading kinesin spindle protein inhibitor, is redefining cell cycle arrest and anti-proliferative assay precision in cancer research. This article uniquely bridges advanced in vitro methodology with practical protocol guidance for robust drug response evaluation.

• Protease Inhibitor Cocktail (100X H₂O, EDTA Plus): Benchmark

  2026-07-01

  The Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) is a broad-spectrum, ready-to-use protease inhibitor mixture designed for robust protein stability during extraction. This product from APExBIO enables high-fidelity analysis in workflows where protein degradation by endogenous proteases threatens data quality. Its validated composition and application scope make it a central tool for modern protein and lipid metabolism research.

• Hyperoside-Regulated lncRNAs Promote Pigeon Pea Seed Set

  2026-06-30

  Qi et al. (2025) reveal that the flavonoid hyperoside increases pigeon pea seed production by upregulating two long noncoding RNAs (lnc187 and lnc999), which orchestrate phosphorylation signaling crucial for pollen tube growth. This discovery highlights a regulatory axis integrating small-molecule cues and noncoding RNA control in plant reproductive development.

• Chlorpromazine Hydrochloride in Antipsychotic Research Workf

  2026-06-30

  Chlorpromazine hydrochloride is more than a benchmark antipsychotic—it unlocks advanced modeling and functional studies in dopamine signaling and antiemetic research. This guide delivers practical workflows, troubleshooting, and actionable insights for maximizing its translational and assay power across neuropharmacology and nanoparticle studies.

• GSK-923295: Applied CENP-E Inhibitor Workflows in Mitosis Re

  2026-06-29

  GSK-923295 enables precise, reproducible disruption of mitotic progression by targeting CENP-E, making it a gold standard for exploring chromosome alignment regulation and cell cycle arrest in mitosis. This guide delivers optimized protocols, troubleshooting strategies, and real-world insights for leveraging GSK-923295 in advanced cancer research and centromere function studies.

• Practical Guidance for Angiotensin I/II (1-5) in RAS Researc

  2026-06-29

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for modeling the renin-angiotensin system in cardiovascular and renal research. Its use is limited to workflows focused on blood pressure regulation and aldosterone signaling, and it should not be applied in unrelated peptide or signaling studies due to its specific biochemical and solubility characteristics.

• Chronic Cabozantinib Exposure: Mechanisms, Models, and Strat

  2026-06-28

  This article synthesizes recent phosphoproteomic insights and translational strategies for researchers leveraging Cabozantinib (XL184, BMS-907351) in renal cell carcinoma (RCC) and beyond. With a mechanistic focus on timescale-dependent kinase remodeling and motility adaptation, it delivers actionable guidance for experimental design, protocol choices, and resistance modeling—supported by current evidence and APExBIO’s product reliability.

• GSK J4 HCl: Potent JMJD3 Inhibitor for Epigenetic Regulation

  2026-06-27

  GSK J4 HCl is a selective, cell-permeable inhibitor of the JMJD3 demethylase, central to chromatin and transcriptional research. It modulates histone H3K27 methylation, suppresses inflammatory cytokine production, and is validated for in vivo and in vitro epigenetic studies.

• Amplifying Immunodetection: HyperFluor™ 488 in Translational

  2026-06-26

  This thought-leadership article illuminates the mechanistic, strategic, and translational impact of the HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody for researchers tackling rapidly-evolving immunological challenges such as SARS-CoV-2 vaccine development. By bridging state-of-the-art mechanistic insights with practical protocol guidance, we position this Alexa Fluor 488 conjugated secondary antibody as essential for robust, reproducible, and clinically relevant immunoassays—outperforming conventional reagents in sensitivity, specificity, and workflow adaptability.

• Salvianolic Acid B: Mechanistic Insights for Fibrosis Innova

  2026-06-26

  Explore how Salvianolic acid B (Dan Shen Suan B) offers a mechanistically distinct approach as an antifibrotic agent. This article uniquely analyzes its role in LH2-mediated collagen remodeling, going beyond protocol workflows to guide innovative pulmonary fibrosis research.

• tFUS Mitigates Stroke-Induced Neuroinflammation via SHP2 Pat

  2026-06-25

  This study demonstrates that transcranial focused ultrasound stimulation (tFUS) alleviates NLRP3-mediated neuroinflammation after ischemic stroke by regulating the Nespas/miR-383-3p/SHP2 axis. These findings clarify a noninvasive mechanism to suppress microglial inflammatory responses, highlighting SHP2 as a promising target for neuroprotection.

• Neuroligin 1 Loss Drives D2-MSN Hyperactivity and Repetitive

  2026-06-25

  This study reveals that Neuroligin 1 deficiency in striatal D2 receptor-expressing medium spiny neurons leads to their hyperactivation and promotes restricted, repetitive behaviors characteristic of autism spectrum disorder. Single-nucleus RNA sequencing further implicates PKC overactivation as a mechanistic link, suggesting targeted intervention strategies for ASD.

• Strategic DNA Repair Inhibition: ABT-888 and Next-Gen Oncolo

  2026-06-24

  Explore how ABT-888 (Veliparib) advances translational cancer research by targeting DNA repair in chemotherapy and radiation sensitization, with a focus on mechanistic insights, emerging biomarkers, and actionable guidance for experimental design.

11553 records 1/771 page Next 12345 下5页 Last page